Geometry.Net - Health_Conditions: Beryllium Disease


Home - Health_Conditions - Beryllium Disease

e99.com Bookstore

Images

Newsgroups

81-100 of 101 Back | 1 | 2 | 3 | 4 | 5 | 6 | Next 20

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Beryllium Disease: more detail

Chronic beryllium disease and sensitization at a beryllium processing facility.(Research/ Environmental Medicine): An article from: Environmental Health Perspectives by Kenneth Rosenman, Vicki Hertzberg, et all 2005-10-01
Beryllium Disease: A Summary of the Occupational Health Concern by Renzo Bertolini, 1989
ANALYSES OF FACTORS IN BERYLLIUM ASSOCIATED DISEASES by M.D. John F. Zielinski, 1962
Managing Health Effects of Beryllium Exposure by Committee on Beryllium Alloy Exposures, Committee on Toxicology, et all 2008-09-30
Report on the beryllium problem: As discussed at the sixth Saranac Symposium, Saranac Lake, N.Y., 27 September to 3 October, 1947 by W. E Park, 1947
Beryllium toxicity (Case studies in environmental medicine) by Dennis M Green, 1997

lists with details

Beryllium Sensitization Progresses To Chronic Beryllium Disease
4285.0 Tuesday, November 14, 2000 522 PM. Abstract 17077. Beryllium Sensitization Progresses to Chronic beryllium disease. Lee
http://apha.confex.com/apha/128am/techprogram/paper_17077.htm

Extractions: Lee S Newman, MD, MA , Margaret M Mroz, MSPH, Elaine M Daniloff, MSPH, Lisa A Maier, MD, MSPH, and Ronald Balkissoon, MD, DIH. Division of Environmental and Occupational Health Sciences, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206, 303-388-4461, newmanl@njc.org Background: Medical screening and surveillance with the blood beryllium lymphocyte proliferation test (BeLPT) results in the identification of both beryllium sensitization (BeS) and chronic beryllium disease (CBD). BeS has been shown to precede CBD, but the frequency and rate of progression from sensitization to disease is unknown. Methods: Between 1987 and 1997 we have identified 75 individuals with BeS who, at the time of their initial assessment, had repeatedly abnormal blood BeLPTs without demonstrable CBD. We follow this cohort of patients every two years with clinical evaluation including transbronchial lung biopsy. Results: Of our 75 patients, 46 (61.3%) have been reevaluated, ten more than once. Eleven of the 46 patients (23.9%) have developed CBD demonstrated by granulomas on biopsy. The follow-up period from BeS to disease development was 2.6 years (1.0 - 9.5 years) resulting in a conversion rate of 9.2% per year. Follow-up time for the other 35 patients was 2.9 years (0.6 - 7.3 years). If we conservatively assume that none of the 29 other subjects progress, the frequency of progression is 14.7%; 5.6% per year. However, not all BeS patients may develop granulomatous lung disease.
Your Health - Berylliosis
Berylliosis. (beryllium disease). by Rick Alan. Definition. Berylliosis is an occupational lung disease. It occurs in people who work with beryllium.
http://www.aurorahealthcare.org/yourhealth/healthgate/getcontent.asp?URLhealthga
Airborne Particulate Matter Research Projects
Project Title beryllium disease Surveillance/Research. Grant/Contract Keyword(s) beryllium, respiratory disease, genetic susceptibility, workers.
http://www.pmra.org/pmra/PM.nsf/WebProj/0A675BA9E5C4CB0B852568D3001E8A60

Extractions: Project Title: Beryllium Disease Surveillance/Research Grant/Contract #: Principal Investigator(s): Kreiss Kathleen Principal Investigator(s) E-Mail: KKreiss@cdc.gov Research Organization: NIOSH City: Morgantown State: WV Country: USA Sponsoring Organization: NIOSH Sponsoring Org. Contact Person: Kreiss Kathleen Contact Person E-mail: KKreiss@cdc.gov Year Began: Year Ending : Funding Per Year: Total (Multiyear) Funding: Status: ongoing NRC Priority Number(s): Not Categorized Research Category: Epidemiology Location of Study: Keyword(s): beryllium, respiratory disease, genetic susceptibility, workers Abstract: This research extends a well-characterized beryllium-exposed cohort for cumulative incidence of beryllium disease, genetic and other risk factors, and exposure-response relations using new measurement techniques. The Division of Respiratory Disease Studies conducts exposure assessment and analyzes questionnaire interviews, screening blood tests for beryllium allergy, and clinical diagnostic information from a beryllium company, with genetic analyses from the Health Effects Laboratory Division and exposure reconstruction from the Division of Surveillance, Hazard Evaluations, and Field Studies. Understanding the level of beryllium exposure that results in disease among workers with increased genetic susceptibility can guide prevention efforts, affect rulemaking now underway at the Department of Energy, and inform efforts to prevent occupational asthma, a more common lung disease with both genetic and exposure components.
Beryllium And What You Need To Kown
Total Sensitized 14. Chronic beryllium disease 7. KCP Former workers and Subcontractors as of 8/31/02. What is beryllium disease (Berylliosis)?
http://www.lodge778.org/beryllium.htm

Extractions: The intention of this page is to provide information about Beryllium Disease. In time you will find links (blue colored) to other web site that contain information about Beryllium or the laws that concern beryllium and its diseases. This page will continue to change visit often. Present employees: as of 3/15/2003 Total enrolled in Beryllium surveillance 1,136 Current Associates: Physical examination 1,130 Initial LPT (blood test performed) 1,130 Total Sensitized: 14 Chronic Beryllium Disease: 7 KCP Former workers and Subcontractors: as of 8/31/02 Former workers enrolled 4072 Former Workers what have received initial screening 2651 Subcontractors enrolled 129 Subcontractors what have received initial screening 127 Diagnosed Sensitized: Former Workers 47 Subcontractors 1 Diagnosed CBD: Former Workers 3 Subcontractors Medical Surveillance Enrollment Process Current Workers Forms Available that Medical Care Services Former Workers Contact Bill Stange, PhD (ORISE) 1-800-269-0157 ext. 8
Beryllium Disease Expert To Lecture In Mid-Columbia
beryllium disease expert to lecture in MidColumbia. Mid-Columbia doctors should be better prepared to treat chronic beryllium disease after this week.
http://www.tri-cityherald.com/news/2001/0115/Story5.html

Extractions: Herald staff writer Mid-Columbia doctors should be better prepared to treat chronic beryllium disease after this week. It's a respiratory illness caused by exposure to the exotic metal beryllium making nuclear sites such as Hanford one of the relatively few places in the world where it's seen. Consequently, few doctors know much about the disease. However, the Hanford Environmental Health Foundation is bringing the doctor who has written much of the medical literature on the disease to the Tri-Cities this week. "Our goal is to provide as much current information as possible and to establish resources for the local providers," said Dr. William Brady, Hanford medical director. Dr. Lee Newman of Denver will meet with the Benton-Franklin County Medical Society, other health groups, Hanford management, Hanford's Beryllium Awareness Group and concerned Hanford workers and their families Tuesday through Friday. He'll be discussing detection, diagnosis and prevention.
HLA-DPB1 And Chronic Beryllium Disease
HLADPB1 and chronic beryllium disease. HLA-DPB1 and Chronic beryllium disease is one in a series of reviews available from the Human
http://bioresearch.ac.uk/cgi/fullRecord.cgi?key=20056610&gateway=bioresearch
HLA-DPB1*E69 And Chronic Beryllium Disease
HLADPB1*E69 and chronic beryllium disease. HLA-DPB1*E69 and Chronic beryllium disease is one in a series of fact sheets available
http://bioresearch.ac.uk/cgi/fullRecord.cgi?key=20056572&gateway=bioresearch
Policy Analysis And Clinical Research On Occupational Beryllium Exposure At DOE
Adoption of this standard has effectively eliminated the presence of acute beryllium disease. Laboratory Research on Chronic beryllium disease.
http://www.cresp.org/dcwrkshp/posters/be/be.html

Extractions: This research supported in part by CRESP through the Department of Energy Cooperative Agreement #DE-FC01-95EW55084. This support does not constitute endorsement of views expressed. The US Department of Energy has used beryllium in nuclear materials production, reactor rod fabrication, nuclear vessel cladding and many other uses since the 1940s. The industrial use of beryllium was found to result in an acute respiratory disease, acute beryllium disease, leading the Atomic Energy Commission to establish an airborne concentration standard of 2 µg/m3 for the workplace based on then accepted standards for other metals. Adoption of this standard has effectively eliminated the presence of acute beryllium disease. However, epidemiologic studies carried out during the 1980-90s has revealed the presence of another form of lung disease, chronic beryllium disease (CBD), among workers at US DOE sites. In 1997, the Consortium for Risk Evaluation with Stakeholder Participation (CRESP) began a series of research efforts to investigate the prevalence of CBD among former beryllium workers at Hanford, evaluation of alternatives to the current screening tools for identifying pre-clinical disease, and policy implications of alternative occupational health program designs to reduce disease incidence among future beryllium workers, such as those involved in decontamination and decommissioning former beryllium facilities.
Consortium For Risk Evaluation With Stakeholder Participation - CRESP Update: Ha
Winter 1999. Worker Health and Safety. Hanford Workers Studied For beryllium disease. by Deirdre Grace*. Dr. Timothy Takaro, Technical
http://www.cresp.org/update/hanwin99.html

Extractions: by Deirdre Grace* Dr. Timothy Takaro, Technical Director of CRESP-UW's Worker Health and Safety Task Group, and colleagues have determined that workers at the Hanford Nuclear Reservation may be at risk from exposure to beryllium used to seal fuel rods for the reactors that produced plutonium. Beryllium is a strong, lightweight metallic element used not only in connection with weaponry, but also in the aerospace industry and, increasingly, in the manufacture of consumer goods like golf clubs and bicycles. Dr. Takaro emphasizes the complexity of studying occupational diseases. "It's critical that the first case - or 'sentinel event' - is diagnosed correctly with a disease like CBD," he stated in a recent interview. "Once CBD has been correctly identified, our challenge becomes looking at the surrounding occupational population and figuring out whether other people have been exposed and what kind of risks they may face." Although in rare, extreme cases, CBD can kill within a few years, most people respond well to treatment once diagnosed and continue to live for decades with the help of medication. Increasing the urgency of this research is the discovery that a small number of people appear to be genetically predisposed to develop a sensitivity to beryllium even if exposed to extremely low quantities of the substance, such as a single, low-dose event. To gain a greater understanding of who might be at risk for this condition, CRESP-UW Worker Health and Safety and Human Health Identification task groups have been researching genetic biomarkers for information on genetic differences across populations. One biomarker, Glu-69, has shown a high correlation with CBD development, but other genetic factors yet to be studied are involved as well.
Seminar At WVU To Focus On Chronic Beryllium Disease
Friday August 30, 2002. Seminar at WVU to focus on Chronic beryllium disease. CONTACT Ainsley Weston, NIOSH CDC, 304285-6221. A toxicologist
http://www.nis.wvu.edu/2002_Releases/BeryilliumDisease.htm

Extractions: News Release Back to Newsroom Friday August 30, 2002 Seminar at WVU to focus on Chronic Beryllium Disease CONTACT: Ainsley Weston , NIOSH CDC, 304-285-6221 A toxicologist from the National Institute for Occupational Safety and Health (NIOSH) Centers for Disease Control and Prevention will speak on "Genetic Factors in Chronic Beryllium Disease" at 3:30 p.m. Tuesday, Sept. 3, in Room 2001 of the Agricultural Sciences Building, Evansdale Campus. Ainsely Weston will give the next presentation in a seminar series organized by West Virginia Universitys interdisciplinary program in Genetics and Developmental Biology. A strong, lightweight, alkaline earth element with a high melting point, beryllium has been used most successfully in components of nuclear reactors nuclear weapons, aircraft and spacecraft. Beryllium compounds are used in ceramics for electronics, in dental bridges and in some sports equipment. Exposure to beryllium in the workplace may lead to various diseases including chronic beryllium disease, which causes a painful scarring of the lung tissue. Workers in certain occupations and industries are most likely to develop the disease. However even a family member can develop chronic beryllium disease from exposure to dust on the workers clothing hair or body.
Chronic Beryllium Disease Prevention Program-Provides Information And Resources
Chronic beryllium disease Prevention Program Provides information and resources on the health and safety aspects of beryllium More information is available at
http://www.scitechresources.gov/Results/show_result.php?rec=1280
Chronic Beryllium Disease And Cancer Risk Estimates With Uncertainty For Berylli
Chronic beryllium disease and Cancer Risk Estimates with Uncertainty for Beryllium Released to the Air from the Rocky Flats Plant, atmospheric transport
http://ehp.niehs.nih.gov/docs/1999/107p731-744mcgavran/abstract.html

Extractions: . Predicted air concentrations were well below the current reference concentration derived by the EPA for beryllium sensitization. Key words : atmospheric transport modeling, beryllium, chronic beryllium disease, exposure assessment, lung cancer, uncertainty. Environ Health Perspect 107:731-744 (1999). [Online 3 August 1999] http://ehpnet1.niehs.nih.gov/docs/1999/107p731-744mcgavran/ abstract.html Address correspondence to P.D. McGavran, 841 Harcourt Road, Boise, ID 83702-1817. Telephone: (208) 336-5617. Fax: (208) 336-0045. E-mail: mcgavran@micron.net
Rates Of Beryllium Disease On The Rise
beryllium disease slowly destroys the lungs after the dust is inhaled. Newspaper Article Source Toledo Blade. Beryllium dangers were kept secret.
http://www.biomed.lib.umn.edu/hmed/1999/03/19990329_ber.html

Extractions: View abstracts from: Search all years Health and Medicine in the News Beryllium dangers were kept secret A recent investigation into the safety practices at a beryllium plant in Ohio has found that federal officials knew of the risks to workers but did little rectify the situation. Beryllium disease slowly destroys the lungs after the dust is inhaled. Toledo Blade. Beryllium dangers were kept secret. Star Tribune, 1999 March 29: A4(col. 1-4). Kreiss K., et al. Risks of beryllium disease related to work processes at a metal alloy and oxide production plant. Occupational and Environmental Medicine 1997 Aug; 54. lam /03/30/1999 MNCAT BioMedSearch MEDLINE Library Instruction ... BIS Bio-Medical Library
Blackwell Synergy - Cookie Absent
Chronic beryllium disease immunemediated destruction with implications for organ-specific autoimmunity. AP Fontenot 1 + , BL Kotzin 1. beryllium disease.
http://www.blackwell-synergy.com/links/doi/10.1046/j.1399-0039.2003.00160.x/full

Extractions: Home An Error Occurred Setting Your User Cookie A cookie is a small amount of information that a web site copies onto your hard drive. Synergy uses cookies to improve performance by remembering that you are logged in when you go from page to page. If the cookie cannot be set correctly, then Synergy cannot determine whether you are logged in and a new session will be created for each page you visit. This slows the system down. Therefore, you must accept the Synergy cookie to use the system. What Gets Stored in a Cookie? Synergy only stores a session ID in the cookie, no other information is captured. In general, only the information that you provide, or the choices you make while visiting a web site, can be stored in a cookie. For example, the site cannot determine your email name unless you choose to type it. Allowing a web site to create a cookie does not give that or any other site access to the rest of your computer, and only the site that created the cookie can read it. Please read our for more information about data collected on this site.
Beryllium Disease, "A Disaster Waiting To Happen," Chicago Tribune Investigation
smallRW.gif (2706 bytes), beryllium disease, A Disaster Waiting To Happen, Chicago Tribune Investigation. CHICAGO, July 28 /PRNewswire
http://www.riskworld.com/PressRel/2001/01q3/PR01a008.htm

Extractions: Beryllium Disease, "A Disaster Waiting To Happen," Chicago Tribune Investigation CHICAGO, July 28 / PRNewswire A Chicago Tribune investigation has found that thousands of Americans are at risk for developing a chronic, potentially fatal lung disease because companies have exposed them to the highly toxic metal beryllium without adequate safeguards or warnings. The story by reporter Sam Roe is published in the Sunday, July 29, Chicago Tribune The Tribune investigation, based on thousands of court, industry and government documents and dozens of interviews with health officials and business owners, found: Many businesses are not taking basic precautions, such as air monitoring. In a spot check of 30 businesses across the country working with beryllium, the Tribune found that none were following the safeguards recommended by the Occupational Safety and Health Administration (OSHA). Warnings from beryllium manufacturers and distributors are often inaccurate, misleading and incomplete. Of 10 warnings reviewed by the Tribune, nine failed to abide by OSHA rules and four failed to even mention beryllium disease. OSHA rarely inspects companies that handle beryllium. Several Chicago-area businesses working with the metal have not been inspected in 10 years.
Berylliosis Lawsuit Overview - Find Trial Lawyers And Attorneys With Experience
Berylliosis, also known as chronic beryllium disease (CBD), can occur after long term exposure to the metal beryllium. Berylliosis
http://www.injuryboard.com/view.cfm/Topic=286

Extractions: June 2, 2004 Dietary supplements containing the herbal stimulant ephedra were banned from sale in the United States by the FDA in 2004. Vioxx / Rofecoxib Tractor-Trailer Accidents Serzone / Nefazodone Hydrochloride Tort Reform ... Injuries Berylliosis: Overview If you or a family member has been injured, contact a personal injury attorney today. Just fill out InjuryBoard.com's on-line questionnaire and have a personal injury lawyer review your potential personal injury claim - free of charge. Ask an Attorney Berylliosis, also known as chronic beryllium disease (CBD), can occur after long term exposure to the metal beryllium . Berylliosis causes noncancerous lesions to form in the lungs . Symptoms associated with berylliosis include irritation of the mucous membranes, reduced lung capacity shortness of breath fatigue , anorexia, dyspnea, malaise, heart failure , and weight loss. Berylliosis may cause death Would you like to use this material on your law firm web site? What do I do Now? As with many personal injury claims, time is critical.
EPA: Federal Register: Chronic Beryllium Disease Prevention Programs; Worker Saf
Chronic beryllium disease Prevention Programs; Worker Safety and Health , Federal Register document.
http://www.epa.gov/fedrgstr/EPA-IMPACT/2003/December/Day-08/i30287.htm

Extractions: and Regulations rule851.comments@hq.doe.gov noting ``Worker Safety and Health Rule Comments'' in the subject line. Where possible, commenters should identify the specific section to which they are responding. Copies of the public hearing transcripts, written comments received, and any other docket material may be reviewed on the Web site specially established for this proceeding. The Internet Web site is http://www.eh.doe.gov/whs/rulemaking The public hearings for this rulemaking will be held at the following addresses: Arlington, VA (Washington, DC): Marriott Crystal City Hotel, 1999 Jefferson Davis Highway, Arlington, VA 22202. Golden, CO (Denver): DOE National Renewable Energy Laboratory, Visitor Center, Auditorium, 15013 Denver West Parkway, Golden, CO 80401 (I-70, Exit 263, right at top of exit ramp if coming from Denver, left at stop sign, building on right). For more information concerning public participation in this rulemaking proceeding, see section IV of this notice of proposed rulemaking (Public Comment Procedures). FOR FURTHER INFORMATION CONTACT: Jacqueline D. Rogers, U.S. Department of Energy, 1000 Independence Avenue SW., Washington, DC 20585-0270, 301-903-5684, e-mail:
Am. J. Epidemiol. -- Abstracts: McCanlies Et Al. 157 (5): 388
of Public Health HUMAN GENOME EPIDEMIOLOGY (HuGE) REVIEW. HLADPB1 and Chronic beryllium disease A HuGE Review. Erin C. McCanlies
http://aje.oupjournals.org/cgi/content/abstract/157/5/388

Extractions: Toxicology and Molecular Biology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV. The human leukocyte antigen (HLA) complex is a series of genes located on chromosome 6 that are important in normal immune function. Susceptibility to chronic beryllium disease, a granulomatous
Ingenta: Article Summary -- HLA-DPB1 And Chronic Beryllium Disease: A HuGE Revie
Article HLADPB1 and Chronic beryllium disease A HuGE Review American Journal of Epidemiology 1 March 2003, vol. 157, no. 5, pp.
http://www.ingenta.com/isis/searching/ExpandTOC/ingenta?issue=pubinfobike://oup/
Groups Warn Of Beryllium Lung Disease
http://cnn.com/2001/HEALTH/conditions/09/03/health.metal.reut/index.html

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

81-100 of 101 Back | 1 | 2 | 3 | 4 | 5 | 6 | Next 20